Concepedia

Dasatinib promotes the expansion of a therapeutically superior T-cell repertoire in response to dendritic cell vaccination against melanoma

Devin B. Lowe, Anamika Bose, Jennifer L. Taylor, Hussein Tawbi, Yan Lin, John M. Kirkwood, Walter J. Storkus

OncoImmunology · 2014 · 47 citations · 36 references

DOIFull text

Open access

Concepts

Abstract

TILs, in support of the therapeutic superiority of combined DAS + VAC immunotherapy in the melanoma setting.

References

36

Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer

Suzanne L. Topalian, F. Stephen Hodi, Julie R. Brahmer et al. · New England Journal of Medicine · 2012 · 12.7K citations · Full text

, , +17

Sunitinib Mediates Reversal of Myeloid-Derived Suppressor Cell Accumulation in Renal Cell Carcinoma Patients

Jennifer S. Ko, Arnold H. Zea, Brian I. Rini et al. · Clinical Cancer Research · 2009 · 852 citations

, , +17

The Novel Role of Tyrosine Kinase Inhibitor in the Reversal of Immune Suppression and Modulation of Tumor Microenvironment for Immune-Based Cancer Therapies

Junko Ozao‐Choy, Ge Ma, Johnny Kao et al. · Cancer Research · 2009 · 531 citations · Full text

, , +17

Sunitinib Inhibition of Stat3 Induces Renal Cell Carcinoma Tumor Cell Apoptosis and Reduces Immunosuppressive Cells

Chunyan Zhang, Andreas Herrmann, Yan Du et al. · Cancer Research · 2009 · 495 citations · Full text

, , +17

PGE2-Induced CXCL12 Production and CXCR4 Expression Controls the Accumulation of Human MDSCs in Ovarian Cancer Environment

Nataša Obermajer, Ravikumar Muthuswamy, Kunle Odunsi et al. · Cancer Research · 2011 · 449 citations · Full text

, , +17